Adispell

Preclinical biotech company developing small molecule therapeutics for Alzheimers, Parkinsons and other diseases related to memory loss

placeNew York City, New York, United States calendar_todayFounded 2010 language adispell.com

Innovation

3 patent families — focus: Human necessities; filing pace dormant. Cited 12 times.

YearFilings
20121
20131
20141
20151
20161

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon